The n-Lorem Foundation, based in Carlsbad, CA, is a pioneering organization dedicated to providing experimental antisense oligonucleotide (ASO) medicines to treat patients with nano-rare diseases. With a focus on personalized ASO medicines, n-Lorem leverages over 30 years of innovative leadership to target the unique genetic causes of disease, offering hope and potential help to nano-rare patients worldwide.
Through their mutation-driven approach and commitment to industrializing the treatment of nano-rare patients, n-Lorem maximizes quality at every step of the process, ensuring that each patient receives the very best ASO tailored to their specific genetic mutation. By sharing their learnings and advancements with the community, n-Lorem is at the forefront of bridging genomic discovery to personalized medicine, one patient at a time, for free, for life.
Generated from the website